Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
7.36
-0.14 (-1.87%)
At close: Nov 13, 2026, 4:00 PM EST
7.33
-0.03 (-0.41%)
After-hours: Nov 13, 2026, 7:30 PM EST
Alignment Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 4,905 | 3,912 | 2,672 | 1,801 | 1,432 | 1,167 |
Other Revenue | 36.69 | 37 | 31.63 | 22.7 | 2.61 | 0.69 |
| 4,942 | 3,949 | 2,704 | 1,824 | 1,434 | 1,168 | |
Revenue Growth | 35.87% | 46.06% | 48.25% | 27.16% | 22.81% | 21.74% |
Policy Benefits | 4,352 | 3,460 | 2,406 | 1,623 | 1,250 | 1,039 |
Depreciation & Amortization | 31.67 | 29.8 | 26.27 | 21.41 | 17.27 | 15.81 |
Selling, General & Administrative | 514.49 | 442.49 | 369.81 | 307.43 | 295.65 | 290.99 |
Total Operating Expenses | 4,899 | 3,932 | 2,802 | 1,951 | 1,563 | 1,346 |
Operating Income | 43.28 | 16.27 | -98.59 | -127.82 | -128.64 | -178.07 |
Interest Expense | -16.57 | -15.8 | -23.55 | -21.23 | -18.29 | -17.44 |
Other Non Operating Income (Expenses) | - | 0.02 | 0.06 | 0.56 | -0.08 | 0.23 |
EBT Excluding Unusual Items | 26.71 | 0.48 | -122.08 | -148.48 | -147 | -195.29 |
Merger & Restructuring Charges | - | - | -2.36 | - | - | - |
Impairment of Goodwill | 0.03 | -0.6 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0 | 0.07 | 0.01 | 0.29 | -0.1 | - |
Asset Writedown | - | - | -0.6 | - | - | - |
Legal Settlements | 0.21 | -0.91 | - | - | - | - |
Other Unusual Items | - | - | -3.02 | - | -2.2 | - |
Pretax Income | 26.96 | -0.96 | -128.05 | -148.2 | -149.3 | -195.29 |
Income Tax Expense | -1.96 | 0.02 | 0.02 | -0.02 | 0.34 | - |
Earnings From Continuing Ops. | 28.92 | -0.98 | -128.07 | -148.17 | -149.64 | -195.29 |
Minority Interest in Earnings | - | 0.25 | 0.04 | 0.16 | 0.09 | - |
Net Income | 28.92 | -0.72 | -128.04 | -148.02 | -149.55 | -195.29 |
Net Income to Common | 28.92 | -0.72 | -128.04 | -148.02 | -149.55 | -195.29 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 206 | 198 | 191 | 186 | 181 | 172 |
Shares Outstanding (Diluted) | 206 | 198 | 191 | 186 | 181 | 172 |
Shares Change | 5.04% | 3.78% | 2.46% | 2.76% | 5.38% | 13.03% |
EPS (Basic) | 0.14 | -0.00 | -0.67 | -0.79 | -0.83 | -1.14 |
EPS (Diluted) | 0.14 | -0.00 | -0.67 | -0.79 | -0.83 | -1.14 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 77.04 | 113.15 | -6.65 | -95.18 | -69.2 | -98.54 |
Free Cash Flow Per Share | 0.38 | 0.57 | -0.04 | -0.51 | -0.38 | -0.57 |
Operating Margin | 0.88% | 0.41% | -3.65% | -7.01% | -8.97% | -15.25% |
Profit Margin | 0.58% | -0.02% | -4.74% | -8.12% | -10.43% | -16.72% |
Free Cash Flow Margin | 1.56% | 2.86% | -0.25% | -5.22% | -4.83% | -8.44% |
EBITDA | 74.95 | 46.11 | -72.18 | -106.15 | -111.15 | -162.04 |
EBITDA Margin | 1.52% | 1.17% | -2.67% | -5.82% | -7.75% | -13.88% |
D&A For EBITDA | 31.67 | 29.85 | 26.42 | 21.67 | 17.49 | 16.03 |
EBIT | 43.28 | 16.27 | -98.59 | -127.82 | -128.64 | -178.07 |
EBIT Margin | 0.88% | 0.41% | -3.65% | -7.01% | -8.97% | -15.25% |
Revenue as Reported | 4,942 | 3,949 | 2,704 | 1,824 | 1,434 | 1,168 |